| Stephen Leon Wayne, MD | |
|
3183 W State St, Suite 1201, Bristol, TN 37620-1712 | |
| (423) 764-0987 | |
| (423) 652-2512 |
| Full Name | Stephen Leon Wayne |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 31 Years |
| Location | 3183 W State St, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881687556 | NPI | - | NPPES |
| 3823601 | Medicaid | TN | |
| 3094544 | Medicaid | TN | |
| 010363136 | Medicaid | VA | |
| 007109881 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 30368 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellmont Medical Associates Inc | 8123291739 | 405 |
| Wellmont Medical Associates Inc | 8123291739 | 405 |
News Archive
Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor Altheos licensed from Japanese pharmaceutical company Asahi Kasei Pharma. The license also includes a series of highly active compounds (AK138 series) specifically for topical treatment for glaucoma.
A new study from Sweden found that social benefits often ease the financial burdens experienced by the parents of children recently diagnosed with cancer, but mothers experienced persistently lower income after benefits diminished.
A survey distributed by researchers from the Chinese General Hospital and Medical Center in Manila, Philippines, may have found a link between the number of duty hours and the prevalence of physicians who smoke.
Levels of high-sensitivity C-reactive protein predict the risk for age-related macular degeneration and diabetic macular edema, show results of two independent studies published in JAMA Ophthalmology.
Researchers in the Cedars-Sinai Board of Governors Regenerative Medicine Institute have devised a novel way to generate transplantable corneal stem cells that may eventually benefit patients suffering from life-altering forms of blindness.
› Verified 4 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174808216 PECOS PAC ID: 8123291739 Enrollment ID: O20120627000467 |
News Archive
Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor Altheos licensed from Japanese pharmaceutical company Asahi Kasei Pharma. The license also includes a series of highly active compounds (AK138 series) specifically for topical treatment for glaucoma.
A new study from Sweden found that social benefits often ease the financial burdens experienced by the parents of children recently diagnosed with cancer, but mothers experienced persistently lower income after benefits diminished.
A survey distributed by researchers from the Chinese General Hospital and Medical Center in Manila, Philippines, may have found a link between the number of duty hours and the prevalence of physicians who smoke.
Levels of high-sensitivity C-reactive protein predict the risk for age-related macular degeneration and diabetic macular edema, show results of two independent studies published in JAMA Ophthalmology.
Researchers in the Cedars-Sinai Board of Governors Regenerative Medicine Institute have devised a novel way to generate transplantable corneal stem cells that may eventually benefit patients suffering from life-altering forms of blindness.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Leon Wayne, MD 3183 W State St, Suite 1201, Bristol, TN 37620-1712 Ph: (423) 764-0987 | Stephen Leon Wayne, MD 3183 W State St, Suite 1201, Bristol, TN 37620-1712 Ph: (423) 764-0987 |
News Archive
Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor Altheos licensed from Japanese pharmaceutical company Asahi Kasei Pharma. The license also includes a series of highly active compounds (AK138 series) specifically for topical treatment for glaucoma.
A new study from Sweden found that social benefits often ease the financial burdens experienced by the parents of children recently diagnosed with cancer, but mothers experienced persistently lower income after benefits diminished.
A survey distributed by researchers from the Chinese General Hospital and Medical Center in Manila, Philippines, may have found a link between the number of duty hours and the prevalence of physicians who smoke.
Levels of high-sensitivity C-reactive protein predict the risk for age-related macular degeneration and diabetic macular edema, show results of two independent studies published in JAMA Ophthalmology.
Researchers in the Cedars-Sinai Board of Governors Regenerative Medicine Institute have devised a novel way to generate transplantable corneal stem cells that may eventually benefit patients suffering from life-altering forms of blindness.
› Verified 4 days ago
Steven Wesley Morgan, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3183 W State St, Suite 1201, Bristol, TN 37620 Phone: 423-764-0987 Fax: 423-652-2512 | |
David Albert Brenner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-1121 | |
Dr. George Harold Naramore, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 26 Midway Street, Bristol, TN 37620 Phone: 423-989-4500 Fax: 423-989-4582 | |
Dr. Howard Leftin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-1121 | |
Shawn Keith Nelson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3183 W State St, Suite 1201, Bristol, TN 37620 Phone: 423-764-0987 Fax: 423-652-2512 | |
Douglas Paul Williams, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3183 W State St, Suite 1201, Bristol, TN 37620 Phone: 423-764-1987 Fax: 423-652-2512 | |
Earl Keith Wilson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3183 W State St, Suite 1201, Bristol, TN 37620 Phone: 423-764-0987 Fax: 423-652-2512 |